Informatie:
Fout:
ID
43831
Beschrijving
A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach; ODM derived from: https://clinicaltrials.gov/show/NCT00038415
Link
https://clinicaltrials.gov/show/NCT00038415
Trefwoorden
Versies (2)
- 19-06-16 19-06-16 -
- 20-09-21 20-09-21 -
Geüploaded op
20 september 2021
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Leukemia, Lymphocytic, Chronic NCT00038415
Eligibility Leukemia, Lymphocytic, Chronic NCT00038415
- StudyEvent: Eligibility
Similar models
Eligibility Leukemia, Lymphocytic, Chronic NCT00038415
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
cll binet stage a
Item
patients with binet stage a chronic lymphocytic leukemia (cll)
boolean
C0023434 (UMLS CUI [1,1])
C1511118 (UMLS CUI [1,2])
C1511118 (UMLS CUI [1,2])
who performance status
Item
who performance status of 2 or less.
boolean
C1298650 (UMLS CUI [1])
life expectancy
Item
a life expectancy of at least one year.
boolean
C0023671 (UMLS CUI [1])
age
Item
greater than 18 years of age.
boolean
C0001779 (UMLS CUI [1])
dna extraction
Item
availability of cll cells which can be used for dna extraction and processing.
boolean
C3839098 (UMLS CUI [1,1])
C0332149 (UMLS CUI [1,2])
C0332149 (UMLS CUI [1,2])
platelet count
Item
a platelet count greater than 100 x 109/l.
boolean
C0032181 (UMLS CUI [1])
ID.7
Item
ability to provide full informed consent.
boolean
chemotherapy or radiotherapy
Item
previous chemotherapy or radiotherapy.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
serum electrophoresis monoclonal band
Item
presence of a monoclonal band on serum electrophoresis.
boolean
C0201720 (UMLS CUI [1,1])
C0241988 (UMLS CUI [1,2])
C0241988 (UMLS CUI [1,2])
anti-dna antibodies anti-muscle antibodies
Item
presence of clinically significant levels of anti-dna antibodies, anti-muscle antibodies or rheumatoid factors or who have active autoimmune disease.
boolean
C0236300 (UMLS CUI [1])
C0003241 (UMLS CUI [2,1])
C0026845 (UMLS CUI [2,2])
C0035448 (UMLS CUI [3])
C0004364 (UMLS CUI [4])
C0003241 (UMLS CUI [2,1])
C0026845 (UMLS CUI [2,2])
C0035448 (UMLS CUI [3])
C0004364 (UMLS CUI [4])
hiv antibodies; hepatitis b; hepatitis c
Item
presence of antibodies to human immunodeficiency virus (hiv) and known carriers of hepatitis b or hepatitis c virus.
boolean
C0019683 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
serious medical condition
Item
presence of other serious medical condition e.g. congestive heart failure.
boolean
C0009488 (UMLS CUI [1])
other malignancies
Item
presence of other malignancies.
boolean
C0006826 (UMLS CUI [1])
pregnancy; lactation; not using contraceptive measures
Item
pregnancy, lactation, or not using contraceptive measures.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C2919192 (UMLS CUI [3])
C0006147 (UMLS CUI [2])
C2919192 (UMLS CUI [3])
Other cancer-directed therapy
Item
concurrent use of other anti-cancer therapy.
boolean
C3846427 (UMLS CUI [1])
allergy tetanus vaccine
Item
patients allergic to tetanus vaccine.
boolean
C0571567 (UMLS CUI [1])